Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Promethazine hydrochloride 10 mg oral tablet |
Is a |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
Promethazine hydrochloride 25 mg oral tablet |
Is a |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
promethazinhydrochlorid 5 mg/5 ml oral opløsning |
Is a |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
promethazinhydrochlorid 25 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
Is a |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
promethazinhydrochlorid 25 mg/ml injektionsvæske, opløsning, ampul a 2 ml |
Is a |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
Promethazine hydrochloride 20 mg oral tablet |
Is a |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
Promethazine hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
Promethazine hydrochloride 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
promethazinhydrochlorid 5 mg/5 ml oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
promethazinhydrochlorid 25 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
promethazinhydrochlorid 25 mg/ml injektionsvæske, opløsning, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
Promethazine hydrochloride [hypnotic] see section c8I.. |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
Promethazine HCl [anesthesia] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
Promethazine hydrochloride 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
promethazinhydrochlorid 50 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
promethazinhydrochlorid 6,25 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely promethazine hydrochloride 50 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
promethazinhydrochlorid 25 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
Promethazine hydrochloride 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
promethazinhydrochlorid 25 mg/ml injektionsvæske, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
Promethazine hydrochloride 25 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
Promethazine hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely promethazine hydrochloride 12.5 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
acetaminophen + promethazinhydrochlorid 120 mg/1,5 mg/5 ml farveløs sukkerfri suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
codeinphosphat 10 mg + promethazinhydrochlorid 6,25 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely pethidine hydrochloride 50 milligram and promethazine hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
phenylephrinhydrochlorid + promethazinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
paracetamol + promethazinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
pethidinhydrochlorid + promethazinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
codeinphosphat + promethazinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
promethazinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
dextromethorphanhydrobromid + promethazinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
dextromethorphanhydrobromid 15 mg + promethazinhydrochlorid 6,25 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
phenylephrinhydrochlorid + promethazinhydrochlorid 5 mg/6,25 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
pethidinhydrochlorid 100 mg/2 ml + promethazinhydrochlorid 50 mg/2 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
pethidinhydrochlorid 50 mg + promethazinhydrochlorid 50 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
|
Promethazine hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Promethazine hydrochloride 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Promethazine hydrochloride 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Promethazine hydrochloride 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Promethazine hydrochloride 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Promethazine hydrochloride 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Promethazine hydrochloride 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Promethazine hydrochloride 12.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Promethazine hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Promethazine hydrochloride 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely pethidine hydrochloride 50 milligram and promethazine hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely pethidine hydrochloride 50 milligram and promethazine hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely pethidine hydrochloride 50 milligram and promethazine hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
2 |
Promethazine hydrochloride 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Promethazine hydrochloride 12.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely pethidine hydrochloride 50 milligram and promethazine hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
2 |
Promethazine hydrochloride 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Promethazine hydrochloride 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Promethazine hydrochloride 25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Promethazine hydrochloride 1 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Promethazine hydrochloride 1 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely promethazine hydrochloride 25 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely promethazine hydrochloride 25 milligram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Promethazine hydrochloride 25 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Promethazine hydrochloride 25 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Promethazine hydrochloride 25 mg rectal suppository |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Promethazine hydrochloride 25 mg rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely promethazine hydrochloride 50 milligram/1 each conventional release rectal suppository (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely promethazine hydrochloride 50 milligram/1 each conventional release rectal suppository (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely promethazine hydrochloride 12.5 milligram/1 each conventional release rectal suppository (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely promethazine hydrochloride 12.5 milligram/1 each conventional release rectal suppository (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely promethazine hydrochloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely promethazine hydrochloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely promethazine hydrochloride 1.25 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely promethazine hydrochloride 1.25 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely promethazine hydrochloride 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely promethazine hydrochloride 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely paracetamol 24 milligram/1 milliliter and promethazine hydrochloride 300 microgram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely paracetamol 24 milligram/1 milliliter and promethazine hydrochloride 300 microgram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Codeine phosphate 2 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Codeine phosphate 2 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Codeine phosphate 2 mg/mL and phenylephrine hydrochloride 1 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Codeine phosphate 2 mg/mL and phenylephrine hydrochloride 1 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely pethidine hydrochloride 50 milligram and promethazine hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dextromethorphan hydrobromide 7.5 milligram and paracetamol 500 milligram and promethazine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dextromethorphan hydrobromide 7.5 milligram and paracetamol 500 milligram and promethazine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dextromethorphan hydrobromide 750 microgram/1 milliliter and paracetamol 50 milligram/1 milliliter and promethazine hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely dextromethorphan hydrobromide 750 microgram/1 milliliter and paracetamol 50 milligram/1 milliliter and promethazine hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Promethazine hydrochloride |
Inferred relationship |
Some |
1 |